Affirm Stock On Fire: Up 33% With 5-Day Winning Streak
Affirm (AFRM) – a digital point-of-sale payment and merchant commerce platform – hit a 5-day winning streak, with cumulative gains over this period amounting to 33%. The company’s market cap has surged by about $5.3 Bil over the last 5 days and currently stands at $22 Bil.
Is this an opportunity or a trap? There are only a couple of things to fear in AFRM stock given its overall Strong operating performance and financial condition. Hence, together with its Very High valuation, this makes the stock look Risky (For details, see Buy or Sell AFRM).
But here is the interesting part. You are reading about this 33% move after it happened. The market has already priced in the news. To catch the next winner before the headlines, you need predictive signals, not notifications. High Quality Portfolio is based on an architecture that includes such signals.
Returns vs S&P 500
- Cash Rich, Low Price – CDW Stock to Break Out?
- Years of Rewards: $34 Bil From Eli Lilly Stock
- Costco Wholesale Stock Capital Return Hits $20 Bil
- Arista Networks Stock Hits Key Support – Buying Opportunity?
- Humana Stock Near Crucial Support – Buy Signal?
- Booking Stock Delivers Strong Cash Yield – Upside Ahead?
The following table summarizes the return for AFRM stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | AFRM | S&P 500 |
|---|---|---|
| 1D | 7.0% | 1.2% |
| 5D (Current Streak) | 32.9% | 4.5% |
| 1M (21D) | 45.2% | 7.6% |
| 3M (63D) | -10.2% | 2.6% |
| YTD 2026 | -13.3% | 4.1% |
| 2025 | 22.2% | 16.4% |
| 2024 | 23.9% | 23.3% |
| 2023 | 408.2% | 24.2% |
However, big gains can follow sharp reversals – but how has AFRM behaved after prior drops? See AFRM Dip Buyer Analysis to learn more.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 96 S&P constituents with 3 days or more of consecutive gains and 13 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 40 | 5 |
| 4D | 8 | 5 |
| 5D | 37 | 1 |
| 6D | 5 | 2 |
| 7D or more | 6 | 0 |
| Total >=3 D | 96 | 13 |
Key Financials for Affirm (AFRM)
Last 2 Fiscal Years:
| Metric | FY2024 | FY2025 |
|---|---|---|
| Revenues | $2.3 Bil | $3.2 Bil |
| Operating Income | $-264.8 Mil | $338.0 Mil |
| Net Income | $-517.8 Mil | $52.2 Mil |
Last 2 Fiscal Quarters:
| Metric | 2026 FQ1 | 2026 FQ2 |
|---|---|---|
| Revenues | $933.3 Mil | $1.1 Bil |
| Operating Income | $173.7 Mil | $229.3 Mil |
| Net Income | $80.7 Mil | $129.6 Mil |
While AFRM stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.